M
10b5-1 Plan
$ Value
$508K
Shares
4,532
Price
$112
Filed
Aug 21
Insider
Name
Plewman Patrick
Title
SVP for Diagnostic Services
CIK
0001497368
Roles
Officer
Transaction Details
Transaction Date
2025-08-19
Code
M
Table
Derivative
Ownership
Direct
Equity Swap
No
Shares After
—
Footnotes
This exercise and sale reported were effected pursuant to a Rule 10b5-1 sales plan adopted by the reporting person. | The options vested in three annual installments beginning with the first on February 18, 2021, the second on February 18, 2022 and the final on February 18, 2023.
Filing Info
Plewman Patrick's History
| Date | Ticker | Type | Value |
|---|---|---|---|
| 2026-02-19 | DGX | ▼ | $196K |
| 2026-02-18 | DGX | A | $0 |
| 2026-02-18 | DGX | F | $51K |
| 2026-02-18 | DGX | F | $61K |
| 2026-02-18 | DGX | A | $0 |
| 2026-02-10 | DGX | M | $690K |
| 2026-02-10 | DGX | ▼ | $1.2M |
| 2026-02-10 | DGX | M | $690K |
| 2026-01-28 | DGX | A | $9K |
| 2025-10-21 | DGX | A | $9K |
Other Insiders at DGX (90d)
| Insider | Bought | Sold | Last |
|---|---|---|---|
| CARTER ROBERT B | — | — | 2026-01-28 |
|
PREVOZNIK MICHAEL E
SVP & General Counsel
|
— | $228K | 2026-02-19 |
| WENTWORTH TIMOTHY C | — | — | 2026-04-01 |
|
Plewman Patrick
SVP for Diagnostic Services
|
— | $1.4M | 2026-02-19 |
| Gregg Vicky B | — | — | 2026-01-28 |
|
Doherty Catherine T.
EVP, Regional Businesses
|
— | $5.7M | 2026-02-19 |
|
Davis J. E.
CEO and President
|
— | — | 2026-02-18 |
|
SAMAD SAM
Executive Vice President & CFO
|
— | — | 2026-02-18 |
|
Deppe Michael J
SVP, Corp. Controller & CAO
|
— | — | 2026-02-18 |
| Lassiter Wright III | — | — | 2026-01-28 |
|
KUPPUSAMY KARTHIK
SVP, Clinical Solutions
|
— | — | 2026-02-18 |
|
DELANEY MARK E
SVP & Chief Commercial Officer
|
— | — | 2026-02-18 |